News type
Date end
News memo
On 9 December 2019, the management of the Dutch subsidiary of the Israeli pharmaceuticals group Teva (26,000 employees), which is specialised in generic medicines, signed a European Works Council agreement. The agreement establishes a European Works Council of no more than 30 members, one of whom is for countries with between 75 and 999 employees and two for those with more than 1,000 employees. Countries with less than 75 employees “will be represented by other countries”. It is interesting to note that the geographical scope of the agreement extends further than the EU alone, and includes the United Kingdom, the countries of the European Economic Area (Iceland, Norway, but also Switzerland) and (which is more unusual) Bosnia-Herzegovina, the Republic of Macedonia, and Serbia. Where projects have a transnational dimension, the agreement specifies that “management will use its judgement to decide whether to provide information to the Select Committee concerning significant single country events”.
Source Info
News date